Prevention of HIV transmission/acquisition through informed contraceptive choice
Prevention of HIV transmission/acquisition through informed contraceptive choice
批准号:
9089848
负责人:
ALISON J. QUAYLE
金额:
$39.18万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-25 至 2018-06-30
关键词:
AIDS preventionAcetatesAddressAffinityAndrogen ReceptorAntiviral AgentsBiological Response ModifiersCD4 Positive T LymphocytesCell modelCervix MucusClinicalClinical ResearchCohort StudiesContraceptive AgentsContraceptive methodsContractsDataDown-RegulationEndocervixEnrollmentEpithelialEpithelial CellsEpitheliumEventFemaleGenital systemGlucocorticoid ReceptorHIVHIV-1HealthHigh Risk WomanHormone ResponsiveHumanImmuneImmune responseIn VitroInfantInfectionInjectableInjection of therapeutic agentIntrauterine DevicesInvestigationKnowledgeLaboratoriesLeukocytesLevonorgestrelMacacaMeasuresMediatingMediator of activation proteinMedroxyprogesterone 17-AcetateMethodsModelingMothersMucous body substancePharmaceutical PreparationsPhysiologicalPredispositionProductionProgesterone ReceptorsProgestinsRecommendationRiskRisk FactorsSIVSafetySerumSexual TransmissionSiteSteroidsSystemT-LymphocyteTestingVaginal RingViral Load resultVirus ReplicationWomancontraceptive efficacyhigh riskimprovedmonolayerprogesterone receptor Breceptor bindingreproductive tractresponsereversible contraceptivetransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Despite its availability, affordability and efficacy, there is a concern that depo medroxyprogesterone acetate (depo-MPA, DMPA) increases the susceptibility of women to HIV-1. Accordingly, we seek an improved knowledge of the effects of contraceptive progestins on HIV-1 transmission. Contraceptive steroid effects are highly dependent on receptor-binding and local concentration and macaque studies illustrate the importance of the endocervix in SIV transmission. Still, there are no data on local endocervical concentrations of any contraceptive progestins in women using these medications. Systemically-delivered DMPA is predicted to produce low genital tract concentrations of MPA. MPA's strong affinity for the glucocorticoid receptor (GR) may enable it to modulate immune and physical epithelial barrier functions that promote HIV transmission in the endocervix. As alternatives to DMPA, levonorgestrel (LNG), nomegestrel acetate (NOMAC) and the PR modulator, ulipristal (UL), have poor affinity for the GR and may be delivered in high local concentrations to the genital tract. We hypothesize that high levels of LNG, NOMAC or UL, unlike low levels of MPA, protect the physical and innate epithelial barrier of the endocervix and decrease HIV-1 transmission at this site. We will measure progestin levels in the endocervix of women using DMPA, an LNG-releasing IUD and a progestin-containing vaginal ring and assess effects of progestin type and delivery method on the physical and immune barrier of cervical mucus to HIV-1. Next, we will expose polarized, hormone-responsive endocervical epithelial cells to physiologic levels of contraceptive progestins and follow changes in monolayer integrity, the innate immune response and HIV-1 transmission across this barrier. Lastly we will investigate the susceptibility of endocervical T cells in women using DMPA and the LNG-IUD to HIV-1 and test the hypothesis that epithelial mediators increase T cell susceptibility to HIV-1 under low levels of MPA but not high levels of LNG, NOMAC or UL. Understanding the mechanisms underlying increased HIV-1 transmission in women using DMPA and the differential effects of alternative progestins and delivery methods on transmission events will allow informed recommendation of the safest contraceptive methods for use in at-risk women.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Prevention of HIV transmission/acquisition through informed contraceptive choice
-
批准号:8588629
-
项目类别:
-
资助金额:$49.12万
-
财政年份:2013
-
负责人:ALISON J. QUAYLE
-
依托单位:
Prevention of HIV transmission/acquisition through informed contraceptive choice
-
批准号:8862383
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2013
-
负责人:ALISON J. QUAYLE
-
依托单位:
Prevention of HIV transmission/acquisition through informed contraceptive choice
-
批准号:8706037
-
项目类别:
-
资助金额:$49.91万
-
财政年份:2013
-
负责人:ALISON J. QUAYLE
-
依托单位:
Cervical T Cell Immunity to C. trachomatis
-
批准号:7979772
-
项目类别:
-
资助金额:$14.3万
-
财政年份:2008
-
负责人:ALISON J. QUAYLE
-
依托单位:
Cervical T Cell Immunity to C. trachomatis
-
批准号:7679392
-
项目类别:
-
资助金额:$29.32万
-
财政年份:2008
-
负责人:ALISON J. QUAYLE
-
依托单位:
Cervical T cell immunity to Chlamydia trachomatis
-
批准号:7508879
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2007
-
负责人:ALISON J. QUAYLE
-
依托单位:
Cervical T Cell Immunity to C. trachomatis
-
批准号:6866134
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2004
-
负责人:ALISON J. QUAYLE
-
依托单位:
HUMAN DEFENSIN-5 IN FEMALE GENITAL TRACT IMMUNE DEFENSE
-
批准号:6373592
-
项目类别:
-
资助金额:$14.28万
-
财政年份:1999
-
负责人:ALISON J. QUAYLE
-
依托单位:
HUMAN DEFENSIN-5 IN FEMALE GENITAL TRACT IMMUNE DEFENSE
-
批准号:6170185
-
项目类别:
-
资助金额:$16.43万
-
财政年份:1999
-
负责人:ALISON J. QUAYLE
-
依托单位:
HUMAN DEFENSIN-5 IN FEMALE GENITAL TRACT IMMUNE DEFENSE
-
批准号:2758873
-
项目类别:
-
资助金额:$16.59万
-
财政年份:1999
-
负责人:ALISON J. QUAYLE
-
依托单位:
HUMAN DEFENSIN 5 IN FEMALE GENITAL TRACT IMMUNE DEFENSE
-
批准号:2468593
-
项目类别:
-
资助金额:$11.04万
-
财政年份:1998
-
负责人:ALISON J. QUAYLE
-
依托单位:
Cervical T Cell Immunity to C. trachomatis
-
批准号:7111628
-
项目类别:
-
资助金额:$23.79万
-
财政年份:--
-
负责人:ALISON J. QUAYLE
-
依托单位:
Cervical T Cell Immunity to C. trachomatis
-
批准号:7287838
-
项目类别:
-
资助金额:$24.0万
-
财政年份:--
-
负责人:ALISON J. QUAYLE
-
依托单位:
Cervical T Cell Immunity to C. trachomatis
-
批准号:7491519
-
项目类别:
-
资助金额:$42.91万
-
财政年份:--
-
负责人:ALISON J. QUAYLE
-
依托单位:
海外基金